Jane Street Portfolio holdings
Jane Street Group, founded in 2000 by Tim Reynolds, Rob Granieri, Marc Gerstein, and Michael Jenkins, is a New York City-based quantitative trading firm renowned for its technological prowess and collaborative problem-solving culture. Specializing in liquidity provision and market-making, it trades a vast array of financial products—including equities, bonds, options, and ETFs—across over 200 venues in 45 countries, handling trillions in securities annually. The firm, which employs over 2,600 people across offices in New York, London, Hong Kong, Amsterdam, Chicago, and Singapore, leverages advanced algorithms and a nearly 70-million-line OCaml codebase to dominate markets, notably ETFs, where it plays a critical role as an authorized participant. With net trading revenues exceeding $10 billion annually in recent years, including a record $10.6 billion in 2023, Jane Street has emerged as a secretive yet powerful force in global finance, outpacing traditional Wall Street giants like Goldman Sachs in trading profitability.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$2.52B |
| 2 |
NVIDIA
NVDA
|
+$732M |
| 3 |
ProShares UltraPro QQQ
TQQQ
|
+$555M |
| 4 |
Dell
DELL
|
+$542M |
| 5 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$421M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$4.18B |
| 2 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$1.29B |
| 3 |
Visa
V
|
+$1.12B |
| 4 |
iShares Core MSCI EAFE ETF
IEFA
|
+$918M |
| 5 |
Broadcom
AVGO
|
+$892M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.93% |
| 2 | Consumer Discretionary | 1.52% |
| 3 | Healthcare | 0.84% |
| 4 | Financials | 0.83% |
| 5 | Communication Services | 0.72% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
8951
PUT
Denison Mines
DNN
$2.91B
| $94.2K | ﹤0.01% |
51,800
-18,400
| -26% | -$32.3K |
|
8952
Biote Corp
BTMD
$44.9M
| $94.2K | ﹤0.01% |
16,873
+3,342
| +25% | +$22.3K |
|
|
MITT
8953
TPG Mortgage Investment Trust
MITT
$225M
| $93.9K | ﹤0.01% |
+12,505
| New | +$90.7K |
|
8954
PUT
B2Gold
BTG
$6.64B
| $93.6K | ﹤0.01% |
30,400
+13,000
| +75% | +$37.8K |
|
|
HFRO
8955
Highland Opportunities and Income Fund
HFRO
$407M
| $93.6K | ﹤0.01% |
15,273
-14,204
| -48% | -$86.5K |
|
8956
Kaltura
KLTR
$267M
| $93.2K | ﹤0.01% |
68,520
-55,560
| -45% | -$68.4K |
|
8957
CALL
SelectQuote
SLQT
$121M
| $93.1K | ﹤0.01% |
+42,900
| New | +$141K |
|
|
LUNA
8958
DELISTED
Luna Innovations Incorporated
LUNA
| $93K | ﹤0.01% |
39,590
-88,925
| -69% | -$228K |
|
8959
LanzaTech
LNZA
$69.8M
| $92.3K | ﹤0.01% |
484
-146
| -23% | -$23.9K |
|
|
VTYX
8960
DELISTED
Ventyx Biosciences
VTYX
| $92.2K | ﹤0.01% |
42,272
-103,504
| -71% | -$238K |
|
|
LAC
8961
PUT
Lithium Americas
LAC
$1.17B
| $92.1K | ﹤0.01% |
34,100
+6,300
| +23% | +$16K |
|
|
MIN
8962
Aberdeen Intermediate Income Fund
MIN
$278M
| $91.6K | ﹤0.01% |
+33,693
| New | +$91.7K |
|
8963
PUT
ProShares Short Bitcoin Strategy ETF
BITI
$117M
| $91K | ﹤0.01% |
+2,440
| New | +$97.5K |
|
|
GOEV
8964
DELISTED
Canoo Inc. Class A Common Stock
GOEV
| $90.6K | ﹤0.01% |
4,607
-34,089
| -88% | -$1.14M |
|
8965
Waldencast
WALD
$178M
| $90.5K | ﹤0.01% |
24,853
-18,836
| -43% | -$63.5K |
|
8966
Humacyte Inc Warrant
HUMAW
$1.24M
| $90.4K | ﹤0.01% |
50,356
+356
| +0.7% | +$785 |
|
8967
Rimini Street
RMNI
$471M
| $90.1K | ﹤0.01% |
48,680
-47,731
| -50% | -$105K |
|
8968
Eton Pharmaceutcials
ETON
$1.22B
| $90K | ﹤0.01% |
+15,006
| New | +$63.4K |
|
8969
Kodiak Sciences
KOD
$2.84B
| $89.8K | ﹤0.01% |
34,397
-30,000
| -47% | -$79.7K |
|
8970
Shattuck Labs
STTK
$694M
| $89.7K | ﹤0.01% |
25,705
-22,703
| -47% | -$84.6K |
|
8971
CALL
Amplitude
AMPL
$1.41B
| $89.7K | ﹤0.01% |
10,000
-32,300
| -76% | -$275K |
|
8972
PUT
Geron
GERN
$949M
| $89.4K | ﹤0.01% |
+19,700
| New | +$89.6K |
|
8973
MeiraGTx Holdings
MGTX
$1.21B
| $89.4K | ﹤0.01% |
21,442
-31,191
| -59% | -$135K |
|
8974
Monte Rosa Therapeutics
GLUE
$1.35B
| $88.7K | ﹤0.01% |
16,741
-51,005
| -75% | -$257K |
|
|
SRTA
8975
Strata Critical Medical Inc
SRTA
$512M
| $88.4K | ﹤0.01% |
30,079
-4,662
| -13% | -$14.8K |
|
Similar funds
Jane Street's Q3 2024 Portfolio in Review
As of Q3 2024, Jane Street held 10,828 positions worth $453B, up 3.6% from $438B the previous quarter. Its ten largest holdings account for 44% of the portfolio.
Jane Street withdrew a net $18.5B in Q3 2024, closing 1,349 positions and reducing 4,327 holdings. Its most notable exit was iShares Core MSCI International Developed Markets ETF, an estimated $290M position sold in full.
By sector, the portfolio is most concentrated in Technology at 2.9% of assets, down from 4.6% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Jane Street opened a new position in Schwab Short-Term US Treasury ETF worth $424M.
- Jane Street's largest Q3 2024 buy was Schwab Short-Term US Treasury ETF: 17,304,274 shares worth $424M.
- Jane Street added most to State Street SPDR S&P 500 ETF Trust in Q3 2024, an estimated $2.52B increase.
- Jane Street's biggest Q3 2024 reduction was Apple, cutting an estimated $4.18B.
- Jane Street fully exited iShares Core MSCI International Developed Markets ETF in Q3 2024, selling an estimated $290M.
- Jane Street's ten largest holdings make up 44% of its $453B portfolio in Q3 2024.
- Jane Street opened 1,593 new positions and closed 1,349 in Q3 2024.
- Jane Street's portfolio value rose 3.6% quarter-over-quarter to $453B.
Based on Jane Street's 13F filing for Q3 2024, filed 15 Nov 2024.